Carol J Farhangfar (Carol Farhangfar)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Metastatic Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

JCO oncology practice

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kirk D Beebe, Joel R Eisner, Yuelong Guo, Yoichiro Shibata, James M Davison, Josh Uronis, Carol J Farhangfar, Farhang Farhangfar, Jill Mooney, Michael V Milburn, Richard L White, Asim Amin, Marcos E Milla, David M Foureau
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Kathryn F Mileham, Carol J Farhangfar
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non-Small-Cell Lung Cancer? JCO oncology practice (2023)
Joel R Eisner, Gregory M Mayhew, James M Davison, Kirk D Beebe, Yoichiro Shibata, Yuelong Guo, Carol J Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jeffrey M Conroy, Michael V Milburn, David Neil Hayes, Kathryn F Mileham
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer - The Piedmont Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Carol J Farhangfar, Gregory T Scarola, Victoria A Morris, Farhang Farhangfar, Kathryn Dumas, James Symanowski, Jimmy J Hwang, Kathryn F Mileham, Daniel R Carrizosa, R Wendel Naumann, Chad Livasy, Edward S Kim, Derek Raghavan
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients. JCO clinical cancer informatics 6 (2022)
Joel R Eisner, Kirk D Beebe, Gregory M Mayhew, Yoichiro Shibata, Yuelong Guo, Carol J Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jill Mooney, Michael V Milburn, David M Foureau, Richard L White, Asim Amin, Marcos E Milla
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer. Cancer research communications 2 (8) (2022)